XTX Topco’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Buy
17,789
+2,426
+16% +$264K 0.03% 835
2026
Q1
$1.42M Sell
15,363
-8,332
-35% -$837K 0.02% 1137
2025
Q4
$2.42M Buy
23,695
+20,148
+568% +$1.8M 0.06% 448
2025
Q3
$222K Buy
+3,547
New +$193K 0.01% 1763
2025
Q2
Sell
-4,935
Closed -$210K 2651
2025
Q1
$210K Sell
4,935
-26,522
-84% -$1.14M 0.01% 1665
2024
Q4
$961K Buy
31,457
+13,624
+76% +$383K 0.08% 328
2024
Q3
$409K Sell
17,833
-17,325
-49% -$490K 0.03% 964
2024
Q2
$1.02M Buy
35,158
+122
+0.3% +$2.84K 0.09% 356
2024
Q1
$723K Buy
35,036
+21,766
+164% +$467K 0.1% 282
2023
Q4
$359K Sell
13,270
-5,498
-29% -$144K 0.08% 488
2023
Q3
$556K Buy
18,768
+8,935
+91% +$314K 0.1% 334
2023
Q2
$352K Sell
9,833
-47,399
-83% -$1.36M 0.06% 602
2023
Q1
$1.34M Buy
57,232
+665
+1% +$19K 0.28% 26
2022
Q4
$1.54M Buy
+56,567
New +$2.59M 0.33% 24
2022
Q3
Sell
-6,203
Closed -$250K 1201
2022
Q2
$250K Buy
+6,203
New +$307K 0.1% 351

Other funds holding GH

XTX Topco's GH Position: Q2 2026 in Review

XTX Topco increased its Guardant Health (GH) stake by 16% in Q2 2026, buying an estimated $264K and bringing the position to 17,789 shares worth $2.67M. The position accounts for 0.03% of the portfolio, ranked #835.

XTX Topco first reported a position in GH in Q2 2022 and has held it in 15 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • XTX Topco held 17,789 shares of Guardant Health worth $2.67M as of Q2 2026.
  • XTX Topco bought 2,426 Guardant Health shares in Q2 2026, an estimated $264K.
  • Guardant Health made up 0.03% of XTX Topco's portfolio in Q2 2026, its #835 holding.
  • XTX Topco first reported a position in Guardant Health in Q2 2022 and has held it in 15 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.